-Scroll.in Rajasthan has drafted a progressive policy that includes a broader definition of homeless people. But it falls short on other counts. Rajasthan could soon become the first Indian state to draft a policy for the homeless. This could be a historic moment as homelessness is a public health crisis in India. It is caused by the negligence of the government since policies and funds for building shelters that ensure that homeless...

-Livemint.com What’s essential for the unique identification number to continue is a strong law. But what should it look like? A key thrust of the 2012 writ petition filed in the Aadhaar case (Puttaswamy versus Union of India) was that the executive action in implementing Aadhaar was unconstitutional in the absence of a law. Later developments in the case, including the government’s argument that there is no fundamental right to privacy, and...

-Hindustan Times School textbooks in recent decades have frequently become battlegrounds for ideological contestation in India. Most textbook wars are to advance majoritarian perspectives on history and culture. However, a recent very different textbook skirmish broke out about the public and private sectors in healthcare. The story of this ideological clash is bemusing and instructive, illuminating competing perspectives on the nature of education, healthcare and markets in new India. This clash surfaced...

-The Indian Express Issues notice to manufacturer too, seeks replies in 15 days The Food Safety and Standards Authority of India (FSSAI) has issued a showcause notice to Patanjali Ayurved, demanding an explanation on the sale of the atta noodles brand — launched by yoga guru Ramdev — without the food regulator’s approval. Another showcause notice has been issued to Aakash Yog, the manufacturer of the instant noodles, seeking its response as...

-The Times of India NEW DELHI: In an attempt to ease norms for testing and introduction of new medicines in the country, the government has taken steps to fast-track approvals for clinical trials as well as launch of drugs already approved in other countries. Pharmaceutical companies planning to launch new drugs already approved outside India after conducting pre-clinical or toxicological studies on animals will not be required to repeat such studies in...